Innovent Biologics, a leading biopharmaceutical company, has launched its dedicated Environmental, Social, and Governance (ESG) website, underscoring its commitment to sustainable development and ethical business practices.
- Excellent Governance: Innovent maintains transparent corporate governance, ethical business conduct, and robust risk management, ensuring compliance and operational efficiency.
- Promoting Good Health: The company focuses on innovative drug development, including oncology and biomedicine, benefiting millions through patient assistance programs and inclusion in national drug lists.
- Ensuring High-Quality Products: Innovent prioritizes product safety and quality, with stringent global standards across its manufacturing and supply chain operations.
- Empowering Employees: Innovent fosters a diverse and inclusive workplace, supporting career advancement and professional development, achieving high employee satisfaction rates.
- Embracing Ecology: Innovent leads in environmental stewardship with ISO14001-certified production sites, climate targets, and sustainable practices embedded in its operations.
Dr. Michael Yu, Founder and CEO, emphasizes Innovent’s dedication to integrating ESG principles, creating long-term value while fostering transparency and sustainability. The ESG website serves as a comprehensive resource for stakeholders to track Innovent’s progress and initiatives in driving positive societal and environmental impacts.
